Itraconazole IR 40% Pellets
Itraconazole IR 40% WW Pellets – Immediate-Release Triazole Antifungal Pellets for 40% WW Formulation Programs. Rraynex Itraconazole IR WW Pellets provide a distinct 40% immediate-release triazole variant differentiated from the base Itraconazole pellet platform. The system is engineered for consistentMultiparticulate processing and capsule filling at this defined drug load.
Product overview
The 40% WW immediate-release variant addresses antifungal formulations requiring a specific triazole load and IR behavior. Rraynex controls active distribution, particle morphology and residual-solvent parameters to support reproducible manufacturing. Technical specifications are available upon request.
Key characteristics
- Distinct 40% immediate-release triazole variant.
- Controlled active distribution and pellet morphology.
- Suitable for capsule filling and multiparticulate dosage forms.
- Technical support for formulation development and commercial supply.
Product specifications
- Product
- Itraconazole IR 40% Pellets
- Form
- immediate-release Pellets
- Therapeutic category
- Antifungal (Triazole)
- Strength
- 40%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Itraconazole IR 40% Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Itraconazole products from Rraynex
- Itraconazole — Pellets